A client with panic disorder is experiencing anticipatory anxiety. Which of the following statements by the client indicates an understanding of anticipatory anxiety?

Choice A rationale:

Family history of panic disorder is a recognized risk factor, suggesting a genetic predisposition. Anxiety disorders often have a hereditary component.

Choice B rationale:

High blood pressure might not directly lead to panic disorder. However, it could contribute to the overall stress burden on the individual.

Choice C rationale:

Recent weight loss isn't typically associated with an increased risk of panic disorder. Other factors are more relevant to its development.

Choice D rationale:

Allergies aren't linked to an increased risk of panic disorder. This choice lacks a plausible biological or psychological connection.

Choice A rationale:

"I should avoid medications that increase serotonin levels in the brain." While avoiding medications that increase serotonin levels is relevant in some cases, it's not a comprehensive understanding of pharmacological treatment for panic disorder. Serotonin-related medications like selective serotonin reuptake inhibitors (SSRIs) are commonly used for panic disorder treatment.

Choice B rationale:

"Antihypertensives can help reduce physical symptoms of panic attacks." This statement is not accurate. Antihypertensives are not commonly used to treat panic disorder. Medications like beta-blockers may be prescribed to manage some physical symptoms of anxiety, but they are not a primary treatment for panic disorder.

Choice C rationale:

"Antiepileptics can enhance the effects of gamma-aminobutyric acid (GABA) in the brain." This is the correct choice. Antiepileptic medications like pregabalin and gabapentin can indeed enhance the effects of GABA, an inhibitory neurotransmitter that helps reduce anxiety and panic. These medications are sometimes used to manage panic disorder symptoms.

Choice D rationale:

"Tricyclic antidepressants inhibit the reuptake of norepinephrine in the brain." While tricyclic antidepressants have been used historically to treat panic disorder, they are not considered first-line treatments due to their potential side effects and the availability of newer, safer options. The statement in Choice D is accurate but not as relevant to current treatment approaches.